Maria Costa

Maria Costa

Company: Tallac Therapeutics

Job title: Senior Director


TAC-001 as a Promising Combination Partner for Cancer Vaccines 4:45 pm

Introduction to Tallac’s platform of immune-targeted TLR9 agonist antibody conjugates Introduction to TAC-001, a B-cell targeted TLR9 agonist antibody conjugate that triggers innate and adaptive anti-cancer immunity Preclinical rationale for combining TAC-001 with cancer vaccinesRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.